General & Plastic Surgery Devices - Morocco

The General & Plastic Surgery Devices market market in Morocco is expected to generate a projected revenue of US$36.45m by 2024.
With an annual growth rate (CAGR 2024-2029) of 7.29%, the market volume is estimated to reach US$51.83m by 2029.
In comparison to other countries, the United States is anticipated to generate the highest revenue, reaching US$9.84bn in 2024.
Morocco's growing middle class and increasing demand for aesthetic enhancements drive the surge in the General & Plastic Surgery Devices market.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in Morocco is experiencing steady growth due to increasing customer preferences for aesthetic procedures, advancements in technology, and the rising demand for cosmetic surgeries. Customer preferences in Morocco have shifted towards a greater emphasis on physical appearance and self-improvement. This is driven by changing societal norms, increased media exposure, and the desire to enhance one's self-esteem. As a result, there is a growing demand for cosmetic surgeries and aesthetic procedures, leading to a rise in the General & Plastic Surgery Devices market. Trends in the market include the adoption of minimally invasive procedures, such as laser treatments and injectables, which offer less downtime and fewer risks compared to traditional surgical methods. These procedures are becoming increasingly popular among customers in Morocco as they provide quick and effective results with minimal discomfort. Additionally, there is a growing trend towards personalized treatments and customized solutions, as customers seek procedures that cater to their specific needs and desires. Local special circumstances also contribute to the development of the General & Plastic Surgery Devices market in Morocco. The country has a growing middle class with increasing disposable income, which enables more individuals to afford aesthetic procedures. Furthermore, Morocco is a popular destination for medical tourism, attracting patients from neighboring countries and beyond. This influx of medical tourists further drives the demand for General & Plastic Surgery Devices in the country. Underlying macroeconomic factors, such as economic growth and stability, also play a role in the development of the market. Morocco has experienced steady economic growth in recent years, which has led to an increase in consumer spending power. This, coupled with a stable political environment, creates a favorable business climate for the General & Plastic Surgery Devices market to thrive. In conclusion, the General & Plastic Surgery Devices market in Morocco is growing due to changing customer preferences, advancements in technology, and the rising demand for aesthetic procedures. The adoption of minimally invasive procedures, personalized treatments, and the country's status as a medical tourism destination further contribute to the market's development. With a growing middle class and a stable economic and political environment, Morocco presents a promising market for General & Plastic Surgery Devices.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.